Zhou, Yan

No ORCID on file · 6 papers in corpus
article 2025
Additional file 1 of Decreased expression of LEF1 caused defective decidualization by inhibiting IL-11 expression in patients with adenomyosis
·doi:10.6084/m9.figshare.28188567

Supplementary Material 1

article 2025
Additional file 1 of Decreased expression of LEF1 caused defective decidualization by inhibiting IL-11 expression in patients with adenomyosis
·doi:10.6084/m9.figshare.28188567.v1

Supplementary Material 1

other 2025
Decreased expression of LEF1 caused defective decidualization by inhibiting IL-11 expression in patients with adenomyosis
·doi:10.6084/m9.figshare.c.7621620.v1

Abstract Reduced lymphoid enhancer-binding factor 1 (LEF1) expression in patients with adenomyosis during the mid-secretory phase leads to impaired endometrial receptivity, affecting embryo implantation. This study investigated the molecula…

other 2025
Decreased expression of LEF1 caused defective decidualization by inhibiting IL-11 expression in patients with adenomyosis
·doi:10.6084/m9.figshare.c.7621620

Abstract Reduced lymphoid enhancer-binding factor 1 (LEF1) expression in patients with adenomyosis during the mid-secretory phase leads to impaired endometrial receptivity, affecting embryo implantation. This study investigated the molecula…

article 2020
Additional file 2 of Association of polybrominated diphenyl ether (PBDE) levels with biomarkers of placental development and disease during mid-gestation
·doi:10.6084/m9.figshare.12422624

Additional file 2: Figure S1. Diagram of study framework illustrating approach to evaluating relationships between biomarkers of chemical exposure and potential biomarkers of placental development and disease. Figure S2. Immunoreactivity of…

article 2020
Additional file 2 of Association of polybrominated diphenyl ether (PBDE) levels with biomarkers of placental development and disease during mid-gestation
·doi:10.6084/m9.figshare.12422624.v1

Additional file 2: Figure S1. Diagram of study framework illustrating approach to evaluating relationships between biomarkers of chemical exposure and potential biomarkers of placental development and disease. Figure S2. Immunoreactivity of…